ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SBFM vs HCWB // ALTMAN Z-SCORE & DEBT/EQUITY

Sunshine Biopharma Inc. (NASDAQ) VS. HCW Biologics Inc. (NASDAQ) • 15-METRIC TALLY: SBFM 5 — HCWB 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SBFM VS. HCWB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SBFM HCWB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 33.80% 20.00% +13.80 SBFM /gross-margins <GO>
Return on Invested Capital (ROIC) -21.40% -35.00% +13.60 SBFM /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -17.20% -60.00% +42.80 SBFM /operating-margins <GO>
Net Profit Margin -16.50% -60.00% +43.50 SBFM /net-margins <GO>
Revenue Growth (YoY) 4.10% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 1/9 +3.00 SBFM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 27.3 31.3 -3.97 HCWB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.5M $2.6M -$104.8K HCWB /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SBFM REV HCWB REV SBFM GROSS % HCWB GROSS % SBFM FCF HCWB FCF
FY 2025 $36.3M $54.2K 33.8% 20.0% -$5.5M -$13.4M
FY 2024 $34.9M $2.6M 30.6% 37.4% -$14.2M -$14.5M
FY 2023 $24.1M $0 — — -$8.8M -$22.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SBFM // BETA —
HCWB // BETA —